Physiological and QoL Benefits of Qi-Gong in Post-acute Sequelae of Covid-19
Recruiting
N/A
Interventional Study
PASC Post Acute Sequelae of COVID 19
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 20 – 100
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 80 (estimated)
- Sponsor
- POCHIWU · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to determine whether Qi-Gong can improve physiological function and quality of life (QoL) in individuals with post-acute sequelae of SARS-CoV-2 infection (PASC).
Study Objectives:
To assess whether Qi-Gong improves physiological function in individuals with PASC.
To evaluate whether Qi-Gong enhances quality of life in individuals with PASC.
Study Design:
If …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* PASC
* above 20 y/o
Exclusion Criteria:
* Those who cannot cooperate
* Severe schizophrenia
Contacts